Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
147
datasets available to search
ShareScore release 0.9.0
Dataset results
147 results for “vildagliptin”
Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01356381. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia
ClinicalTrials.gov study NCT00101712. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00138580. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00260156. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.
ClinicalTrials.gov study NCT00380380. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01582230. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01309698. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099866. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01867502. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00138541. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan
ClinicalTrials.gov study NCT01758380. IPD Sharing: Not stated. Countries: 16. Publications: 2.
Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%
ClinicalTrials.gov study NCT00101673. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00102388. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and Metformin
ClinicalTrials.gov study NCT01099137. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00390520. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02176681. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%
ClinicalTrials.gov study NCT00138593. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Empagliflozin Versus Vildagliptin in CAD Patients With T2DM
ClinicalTrials.gov study NCT06313008. IPD Sharing: NO. Countries: 1. Publications: 4.
Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin
ClinicalTrials.gov study NCT01703637. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy
ClinicalTrials.gov study NCT01398592. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.